Hangzhou Todaytec Digital (300743.SZ) plans to launch an employee stock ownership plan in 2024.
Tian Di Digital (300743.SZ) disclosed the 2024 employee stock ownership plan (draft), with a total number of participants not exceeding...
Hangzhou Todaytec Digital (300743.SZ) disclosed the 2024 employee stock ownership plan (draft), with a total number of participants not exceeding 66 (excluding reserved shares). The maximum amount of funds raised for the employee stock ownership plan is 7.8411 million yuan, with "shares" as the subscription unit, each share priced at 1 yuan. The maximum number of shares for this employee stock ownership plan is 7.8411 million shares.
The source of the stock for this employee stock ownership plan is the shares repurchased from the company's special repurchase account, at a transfer price of 5.90 yuan per share. After approval by the company's shareholders' meeting, the employee stock ownership plan intends to acquire the company's repurchased shares held in the special repurchase account through legal means allowed by laws and regulations. The total number of shares acquired by the employee stock ownership plan does not exceed 1.329 million shares, accounting for 0.87% of the company's total share capital as of the announcement date of the employee stock ownership plan draft. The final number of shares held will be determined by the actual payment situation. To meet the needs of the company's sustainable development and to continuously attract and retain outstanding talents, this employee stock ownership plan intends to set aside 80,000 shares as reserved shares, accounting for 6.02% of the total shares targeted by this employee stock ownership plan and 0.05% of the company's current total share capital.
Related Articles

JP Morgan is optimistic about the potential of the CRISPR gene editing pipeline and has initiated coverage with an "overweight" rating and a target price of $70 USD.

GMTEight List of A-share restricted sales and lifting restrictions | September 19th

Highlights of the morning meeting of securities firms | Huawei clarifies the iteration plan of the Ascend AI chip, and continues to be optimistic about domestic computing power.
JP Morgan is optimistic about the potential of the CRISPR gene editing pipeline and has initiated coverage with an "overweight" rating and a target price of $70 USD.

GMTEight List of A-share restricted sales and lifting restrictions | September 19th

Highlights of the morning meeting of securities firms | Huawei clarifies the iteration plan of the Ascend AI chip, and continues to be optimistic about domestic computing power.

RECOMMEND

Three-Year R&D Spend Drains RMB 2.4 Billion, Urgent Cash Needs Drive Maiwei Biotech Back to Hong Kong Amid Compliance Scrutiny
18/09/2025

Why Generating Profit Remains Challenging for Lidar Companies
18/09/2025

SEC Adopts Landmark Rule to Restrict Shareholder Class Actions in Bid to Revive IPO Market
18/09/2025